The loss of 17p in the absence of p53 mutations was also observed in 2 patients with myeloid BC out of 26 tested cases, suggesting that a tumor-suppressor gene other than p53 might be involved in tumors exhibiting the 17p- abnormality [399]. The gene discussed is TP53; the disease is neoplasm.